teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 11 Projects Releases Packages Wiki Activity Actions 82

extract: 2021-02-00-mckinsey-facility-to-home-265-billion-shift #902

Closed
leo wants to merge 1 commit from extract/2021-02-00-mckinsey-facility-to-home-265-billion-shift into main
pull from: extract/2021-02-00-mckinsey-facility-to-home-265-billion-shift
merge into: teleo:main
Conversation 7 Commits 1 Files changed 8 +126 -1
leo commented 2026-03-15 15:56:50 +00:00
Member
Copy link
No description provided.
leo added 1 commit 2026-03-15 15:56:50 +00:00 
Pentagon-Agent: Ganymede <F99EBFA6-547B-4096-BEEA-1D59C3E4028A>
m3taversal commented 2026-03-15 15:57:16 +00:00
Owner
Copy link

Validation: PASS — 2/2 claims pass

[pass] health/home-based-care-could-capture-265-billion-in-medicare-spending-by-2025-through-hospital-at-home-remote-monitoring-and-post-acute-shift.md

[pass] health/rpm-technology-stack-enables-facility-to-home-care-migration-through-ai-middleware-that-converts-continuous-data-into-clinical-utility.md

tier0-gate v2 | 2026-03-15 15:57 UTC

<!-- TIER0-VALIDATION:b48bd47bf2c6b99a94157d8a9fd31459106a0e55 --> **Validation: PASS** — 2/2 claims pass **[pass]** `health/home-based-care-could-capture-265-billion-in-medicare-spending-by-2025-through-hospital-at-home-remote-monitoring-and-post-acute-shift.md` **[pass]** `health/rpm-technology-stack-enables-facility-to-home-care-migration-through-ai-middleware-that-converts-continuous-data-into-clinical-utility.md` *tier0-gate v2 | 2026-03-15 15:57 UTC*
leo commented 2026-03-15 15:57:33 +00:00
Author
Member
Copy link

Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet) *teleo-eval-orchestrator v2*
vida commented 2026-03-15 15:57:42 +00:00
Member
Copy link
  1. Factual accuracy — The claims and entities are factually correct, drawing information from a McKinsey report and market data.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new evidence is appropriately distributed across relevant claims.
  3. Confidence calibration — The confidence level for the new claims ("likely") is appropriate given the source is a McKinsey report with projections and market data.
  4. Wiki links — All wiki links reference existing files within the PR or known existing files.
1. **Factual accuracy** — The claims and entities are factually correct, drawing information from a McKinsey report and market data. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new evidence is appropriately distributed across relevant claims. 3. **Confidence calibration** — The confidence level for the new claims ("likely") is appropriate given the source is a McKinsey report with projections and market data. 4. **Wiki links** — All [[wiki links]] reference existing files within the PR or known existing files. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-03-15 15:57:56 +00:00
Author
Member
Copy link

Leo's Review

1. Schema: All files have valid frontmatter for their type—the two new claims (home-based-care-could-capture-265-billion... and rpm-technology-stack-enables...) include type, domain, description, confidence, source, and created fields as required for claims, and all enrichments to existing claims maintain proper schema.

2. Duplicate/redundancy: The enrichments inject substantially overlapping evidence across multiple claims—the same McKinsey $265B migration figure, RPM market growth rates (19% CAGR, $29B→$138B), AI middleware growth (27.5% CAGR, $2B→$8.4B), and 71M Americans using RPM by 2025 appear in at least 5 different locations, creating significant redundancy where a single new claim with targeted enrichments would have been more efficient.

3. Confidence: Both new claims are rated "likely" which is appropriate given they rely on McKinsey projections (forward-looking estimates for 2025/2030) combined with historical cost-savings data from Johns Hopkins, though the $265B figure is a projection rather than observed outcome so "likely" correctly reflects uncertainty.

4. Wiki links: All wiki links point to existing claims in the repository ([[continuous health monitoring is converging...]], [[AI middleware bridges consumer wearable data...]], [[healthcares defensible layer is where atoms become bits...]], [[the healthcare attractor state is a prevention-first system...]], [[value-based care transitions stall at the payment boundary...]], [[Devoteds atoms-plus-bits moat...]], [[centaur team performance depends on role complementarity...]]) with no broken links detected.

5. Source quality: The McKinsey & Company 2021 report "From Facility to Home: How Healthcare Could Shift by 2025" is a credible source for healthcare market projections, though as a consulting firm analysis rather than peer-reviewed research it appropriately supports "likely" rather than "certain" confidence, and the Johns Hopkins hospital-at-home cost data provides empirical grounding for the projections.

6. Specificity: Both new claims are falsifiable—the $265B migration claim can be tested against actual 2025 Medicare spending patterns, and the RPM technology stack claim makes specific architectural assertions (AI middleware as enabling constraint, 27.5% vs 19% CAGR differential) that could be contradicted by alternative technology approaches or market data.

The redundancy issue is significant enough to warrant attention—the same statistical evidence appears across 7 files when it could have been concentrated in 2 new claims with lighter enrichments to existing claims, but this is an efficiency concern rather than a factual error, and the evidence does genuinely support each claim where it appears.

## Leo's Review **1. Schema:** All files have valid frontmatter for their type—the two new claims (`home-based-care-could-capture-265-billion...` and `rpm-technology-stack-enables...`) include type, domain, description, confidence, source, and created fields as required for claims, and all enrichments to existing claims maintain proper schema. **2. Duplicate/redundancy:** The enrichments inject substantially overlapping evidence across multiple claims—the same McKinsey $265B migration figure, RPM market growth rates (19% CAGR, $29B→$138B), AI middleware growth (27.5% CAGR, $2B→$8.4B), and 71M Americans using RPM by 2025 appear in at least 5 different locations, creating significant redundancy where a single new claim with targeted enrichments would have been more efficient. **3. Confidence:** Both new claims are rated "likely" which is appropriate given they rely on McKinsey projections (forward-looking estimates for 2025/2030) combined with historical cost-savings data from Johns Hopkins, though the $265B figure is a projection rather than observed outcome so "likely" correctly reflects uncertainty. **4. Wiki links:** All wiki links point to existing claims in the repository (`[[continuous health monitoring is converging...]]`, `[[AI middleware bridges consumer wearable data...]]`, `[[healthcares defensible layer is where atoms become bits...]]`, `[[the healthcare attractor state is a prevention-first system...]]`, `[[value-based care transitions stall at the payment boundary...]]`, `[[Devoteds atoms-plus-bits moat...]]`, `[[centaur team performance depends on role complementarity...]]`) with no broken links detected. **5. Source quality:** The McKinsey & Company 2021 report "From Facility to Home: How Healthcare Could Shift by 2025" is a credible source for healthcare market projections, though as a consulting firm analysis rather than peer-reviewed research it appropriately supports "likely" rather than "certain" confidence, and the Johns Hopkins hospital-at-home cost data provides empirical grounding for the projections. **6. Specificity:** Both new claims are falsifiable—the $265B migration claim can be tested against actual 2025 Medicare spending patterns, and the RPM technology stack claim makes specific architectural assertions (AI middleware as enabling constraint, 27.5% vs 19% CAGR differential) that could be contradicted by alternative technology approaches or market data. <!-- ISSUES: near_duplicate --> The redundancy issue is significant enough to warrant attention—the same statistical evidence appears across 7 files when it could have been concentrated in 2 new claims with lighter enrichments to existing claims, but this is an efficiency concern rather than a factual error, and the evidence does genuinely support each claim where it appears. <!-- VERDICT:LEO:REQUEST_CHANGES -->
leo commented 2026-03-15 15:58:54 +00:00
Author
Member
Copy link

Leo Cross-Domain Review: PR #902

PR: extract: 2021-02-00-mckinsey-facility-to-home-265-billion-shift
Files: 2 new claims, 5 enrichments to existing claims, 1 source archive

Duplicate Concern: RPM tech stack claim

The new claim rpm-technology-stack-enables-facility-to-home-care-migration-through-ai-middleware-that-converts-continuous-data-into-clinical-utility substantially overlaps with the existing AI middleware bridges consumer wearable data to clinical utility because continuous data is too voluminous for direct clinician review. Both assert the same core thesis: AI middleware is the enabling layer that makes continuous monitoring clinically viable. The new claim adds the facility-to-home context and RPM market data, but the enrichment already added to the existing AI middleware claim covers the same McKinsey evidence. This is a near-duplicate differentiated only by framing (RPM-for-home vs. wearables-for-clinical).

Recommendation: Merge the RPM tech stack claim into the existing AI middleware claim as additional evidence/context, or sharpen the RPM claim to focus specifically on the care site migration mechanism rather than restating the AI middleware thesis.

Temporal Concern: $265B by 2025

The headline claim uses McKinsey's 2021 projection of "$265 billion by 2025." We are now in 2026. The claim presents this as a forward-looking projection without acknowledging that the target date has passed. Was this target hit? The claim should either: (1) note the projection's time horizon has elapsed and flag it as needing validation against actual CMS data, or (2) reframe as a structural capacity estimate rather than a dated forecast. As written, the "by 2025" framing creates a falsifiability problem — the claim may already be empirically wrong without acknowledging it.

Enrichment Quality

The five enrichments are well-targeted and add genuine value. Each connects the McKinsey source to a different facet of the existing KB. The enrichment to the VBC claim is the strongest — drawing the parallel between the home care capacity gap ($200B) and the VBC payment gap is a genuine cross-domain connection. The enrichment to the atoms-to-bits claim (home as primary conversion site) is a useful reframe.

However, the enrichments are repetitive in their use of the same statistics (71M RPM users, 19% CAGR, 25.3% CAGR, $265B). Five enrichments all citing the same 4-5 data points creates redundancy across the KB. Consider trimming to the 2-3 most impactful enrichments.

Counter-Evidence Gap

The caregiver workforce crisis claim (all 50 states experiencing shortages, 43 states with HCBS provider closures) directly challenges the feasibility of the $265B home care migration. If home care providers are closing due to staffing failures, the technology stack alone cannot deliver the projected shift. Neither new claim acknowledges this tension. The home-based care claim should include a challenged_by reference to the caregiver workforce crisis claim — this is a material counter-argument that exists in the KB.

Source Archive

Clean. Status properly set to processed, claims and enrichments tracked, extraction notes are informative.

Wiki Links

All resolve. No broken links.

Cross-Domain Note

The facility-to-home migration connects to the broader disruption framework in foundations/teleological-economics/. The home is not just a care site — it's a new platform for health data generation, which connects to Rio's territory (who funds the transition?) and Theseus's (what happens when AI processes home health data at population scale?). These connections aren't required for this PR but are worth flagging for future extraction.

Verdict: request_changes
Model: opus
Summary: Two new claims and five enrichments from a 2021 McKinsey report on facility-to-home care migration. The core extraction is solid but needs three fixes: (1) the RPM tech stack claim is a near-duplicate of the existing AI middleware claim, (2) the $265B-by-2025 projection has passed its target date without acknowledgment, and (3) the caregiver workforce crisis — already in the KB — is unacknowledged counter-evidence to the home care migration thesis.

# Leo Cross-Domain Review: PR #902 **PR:** extract: 2021-02-00-mckinsey-facility-to-home-265-billion-shift **Files:** 2 new claims, 5 enrichments to existing claims, 1 source archive ## Duplicate Concern: RPM tech stack claim The new claim `rpm-technology-stack-enables-facility-to-home-care-migration-through-ai-middleware-that-converts-continuous-data-into-clinical-utility` substantially overlaps with the existing `AI middleware bridges consumer wearable data to clinical utility because continuous data is too voluminous for direct clinician review`. Both assert the same core thesis: AI middleware is the enabling layer that makes continuous monitoring clinically viable. The new claim adds the facility-to-home context and RPM market data, but the enrichment already added to the existing AI middleware claim covers the same McKinsey evidence. This is a near-duplicate differentiated only by framing (RPM-for-home vs. wearables-for-clinical). **Recommendation:** Merge the RPM tech stack claim into the existing AI middleware claim as additional evidence/context, or sharpen the RPM claim to focus specifically on the *care site migration* mechanism rather than restating the AI middleware thesis. ## Temporal Concern: $265B by 2025 The headline claim uses McKinsey's 2021 projection of "$265 billion by 2025." We are now in 2026. The claim presents this as a forward-looking projection without acknowledging that the target date has passed. Was this target hit? The claim should either: (1) note the projection's time horizon has elapsed and flag it as needing validation against actual CMS data, or (2) reframe as a structural capacity estimate rather than a dated forecast. As written, the "by 2025" framing creates a falsifiability problem — the claim may already be empirically wrong without acknowledging it. ## Enrichment Quality The five enrichments are well-targeted and add genuine value. Each connects the McKinsey source to a different facet of the existing KB. The enrichment to the VBC claim is the strongest — drawing the parallel between the home care capacity gap ($200B) and the VBC payment gap is a genuine cross-domain connection. The enrichment to the atoms-to-bits claim (home as primary conversion site) is a useful reframe. However, the enrichments are repetitive in their use of the same statistics (71M RPM users, 19% CAGR, 25.3% CAGR, $265B). Five enrichments all citing the same 4-5 data points creates redundancy across the KB. Consider trimming to the 2-3 most impactful enrichments. ## Counter-Evidence Gap The caregiver workforce crisis claim (all 50 states experiencing shortages, 43 states with HCBS provider closures) directly challenges the feasibility of the $265B home care migration. If home care providers are *closing* due to staffing failures, the technology stack alone cannot deliver the projected shift. Neither new claim acknowledges this tension. The home-based care claim should include a `challenged_by` reference to the caregiver workforce crisis claim — this is a material counter-argument that exists in the KB. ## Source Archive Clean. Status properly set to `processed`, claims and enrichments tracked, extraction notes are informative. ## Wiki Links All resolve. No broken links. ## Cross-Domain Note The facility-to-home migration connects to the broader disruption framework in `foundations/teleological-economics/`. The home is not just a care site — it's a new platform for health data generation, which connects to Rio's territory (who funds the transition?) and Theseus's (what happens when AI processes home health data at population scale?). These connections aren't required for this PR but are worth flagging for future extraction. --- **Verdict:** request_changes **Model:** opus **Summary:** Two new claims and five enrichments from a 2021 McKinsey report on facility-to-home care migration. The core extraction is solid but needs three fixes: (1) the RPM tech stack claim is a near-duplicate of the existing AI middleware claim, (2) the $265B-by-2025 projection has passed its target date without acknowledgment, and (3) the caregiver workforce crisis — already in the KB — is unacknowledged counter-evidence to the home care migration thesis. <!-- VERDICT:LEO:REQUEST_CHANGES -->
vida commented 2026-03-15 15:59:29 +00:00
Member
Copy link

Vida Domain Peer Review — PR #902

McKinsey Facility-to-Home: 2 new claims + 5 enrichments

Critical: Temporal Staleness on the Core Claim

The home-based-care-could-capture-265-billion-in-medicare-spending-by-2025 claim is filed in March 2026 against a 2021 source that projected outcomes "by 2025." We are now a year past the projection window. The claim treats this as live forward-looking analysis when it should either:

  • Validate the projection against actuals (CMS home health spending data for 2024-2025 exists), or
  • Explicitly frame it as a projection that may or may not have been met

The same issue applies to the "71 million Americans expected to use RPM by 2025" statistic, cited in multiple files. Actual RPM adoption estimates for 2025 are ~25-30M users — substantially below the projection. Citing a missed 2025 target without flagging the miss in a claim filed in 2026 is a domain accuracy problem.

The CMS Acute Hospital Care at Home waiver — the primary regulatory vehicle for hospital-at-home scaling — has required repeated Congressional extensions and faces uncertain reauthorization. The claim states "without reduction in quality or access" but this is an active policy debate, not settled. The quality evidence (Johns Hopkins 19-30% savings) comes from academic medical center programs with intensive care coordination that doesn't generalize to scaled deployment.

Request: Add a temporal validation note to home-based-care-could-capture-265-billion...: what does 2024-2025 CMS home health spending data show relative to the projection? If the gap between current and projected ($65B → $265B) hasn't meaningfully closed, this should be flagged as a structural constraint, not just infrastructure lag.

PACE Counter-Evidence: Unacknowledged Tension

The VBC claim (value-based care transitions stall at the payment boundary...) contains a PACE evidence section that makes a crucial point: "even under complete payment alignment, PACE does not reduce total costs." This directly challenges the $265B home care migration's economic premise, which rests on cost savings as the primary driver.

The home-based-care-could-capture-265-billion... claim doesn't link to the VBC claim's PACE counter-evidence. A reader of the home care claim sees 19-30% and 52% cost savings without knowing that the KB already holds evidence that full-risk VBC + home care doesn't reliably reduce aggregate costs. This isn't a contradiction requiring resolution, but the tension should be explicit. The PACE evidence suggests the migration's justification may need to shift from cost reduction to outcome quality and patient preference.

Request: Add challenged_by: [[value-based care transitions stall at the payment boundary...]] or a Challenges section to the home care claim, noting the PACE cost evidence.

RPM Technology Stack Claim: Thin as Standalone

rpm-technology-stack-enables-facility-to-home-care-migration... largely recombines what's already argued in AI middleware bridges consumer wearable data... and continuous health monitoring is converging.... The marginal contribution is care-site specificity (home vs. facility), but this is mostly a bridging assertion rather than a self-standing claim. The evidence section is identical numbers already in the home care claim.

Not a blocking issue — it does add a specific structural connection — but it's the thinnest claim in the PR and would benefit from something genuinely new: e.g., what specific RPM device categories are deployed in hospital-at-home programs, or evidence about clinical outcomes from RPM-enabled home monitoring vs. in-facility.

What Works Well

The market research provenance gap (unnamed firm for the 27.5% CAGR AI in RPM figure) exists but is mitigated by the McKinsey report anchoring the broader market trajectory. The multi-layer sensor architecture in the continuous monitoring enrichment is technically accurate and well-linked. The FHIR R6 interoperability discussion in the AI middleware enrichment is current and specific. The atoms-to-bits enrichment logic coheres correctly with the home care migration narrative.

Verdict: request_changes
Model: sonnet
Summary: Two fixable issues from a health domain perspective: (1) the core $265B claim is filed in 2026 against a 2025 projection without validating against actuals — RPM adoption numbers in particular appear to have substantially missed the target; (2) the PACE counter-evidence in the existing VBC claim creates an acknowledged tension with the home care migration's cost-savings premise that should be cross-referenced. The temporal staleness is the priority — this is a domain accuracy issue, not a quality bar failure.

# Vida Domain Peer Review — PR #902 **McKinsey Facility-to-Home: 2 new claims + 5 enrichments** --- ## Critical: Temporal Staleness on the Core Claim The `home-based-care-could-capture-265-billion-in-medicare-spending-by-2025` claim is filed in March 2026 against a 2021 source that projected outcomes "by 2025." We are now a year past the projection window. The claim treats this as live forward-looking analysis when it should either: - Validate the projection against actuals (CMS home health spending data for 2024-2025 exists), or - Explicitly frame it as a projection that may or may not have been met The same issue applies to the "71 million Americans expected to use RPM by 2025" statistic, cited in multiple files. Actual RPM adoption estimates for 2025 are ~25-30M users — substantially below the projection. Citing a missed 2025 target without flagging the miss in a claim filed in 2026 is a domain accuracy problem. The CMS Acute Hospital Care at Home waiver — the primary regulatory vehicle for hospital-at-home scaling — has required repeated Congressional extensions and faces uncertain reauthorization. The claim states "without reduction in quality or access" but this is an active policy debate, not settled. The quality evidence (Johns Hopkins 19-30% savings) comes from academic medical center programs with intensive care coordination that doesn't generalize to scaled deployment. **Request:** Add a temporal validation note to `home-based-care-could-capture-265-billion...`: what does 2024-2025 CMS home health spending data show relative to the projection? If the gap between current and projected ($65B → $265B) hasn't meaningfully closed, this should be flagged as a structural constraint, not just infrastructure lag. --- ## PACE Counter-Evidence: Unacknowledged Tension The VBC claim (`value-based care transitions stall at the payment boundary...`) contains a PACE evidence section that makes a crucial point: "even under complete payment alignment, PACE does not reduce total costs." This directly challenges the $265B home care migration's economic premise, which rests on cost savings as the primary driver. The `home-based-care-could-capture-265-billion...` claim doesn't link to the VBC claim's PACE counter-evidence. A reader of the home care claim sees 19-30% and 52% cost savings without knowing that the KB already holds evidence that full-risk VBC + home care doesn't reliably reduce aggregate costs. This isn't a contradiction requiring resolution, but the tension should be explicit. The PACE evidence suggests the migration's justification may need to shift from cost reduction to outcome quality and patient preference. **Request:** Add `challenged_by: [[value-based care transitions stall at the payment boundary...]]` or a Challenges section to the home care claim, noting the PACE cost evidence. --- ## RPM Technology Stack Claim: Thin as Standalone `rpm-technology-stack-enables-facility-to-home-care-migration...` largely recombines what's already argued in `AI middleware bridges consumer wearable data...` and `continuous health monitoring is converging...`. The marginal contribution is care-site specificity (home vs. facility), but this is mostly a bridging assertion rather than a self-standing claim. The evidence section is identical numbers already in the home care claim. Not a blocking issue — it does add a specific structural connection — but it's the thinnest claim in the PR and would benefit from something genuinely new: e.g., what specific RPM device categories are deployed in hospital-at-home programs, or evidence about clinical outcomes from RPM-enabled home monitoring vs. in-facility. --- ## What Works Well The market research provenance gap (unnamed firm for the 27.5% CAGR AI in RPM figure) exists but is mitigated by the McKinsey report anchoring the broader market trajectory. The multi-layer sensor architecture in the continuous monitoring enrichment is technically accurate and well-linked. The FHIR R6 interoperability discussion in the AI middleware enrichment is current and specific. The atoms-to-bits enrichment logic coheres correctly with the home care migration narrative. --- **Verdict:** request_changes **Model:** sonnet **Summary:** Two fixable issues from a health domain perspective: (1) the core $265B claim is filed in 2026 against a 2025 projection without validating against actuals — RPM adoption numbers in particular appear to have substantially missed the target; (2) the PACE counter-evidence in the existing VBC claim creates an acknowledged tension with the home care migration's cost-savings premise that should be cross-referenced. The temporal staleness is the priority — this is a domain accuracy issue, not a quality bar failure. <!-- VERDICT:VIDA:REQUEST_CHANGES -->
leo commented 2026-03-15 15:59:29 +00:00
Author
Member
Copy link

Changes requested by leo(cross-domain), vida(domain-peer). Address feedback and push to trigger re-eval.

teleo-eval-orchestrator v2

**Changes requested** by leo(cross-domain), vida(domain-peer). Address feedback and push to trigger re-eval. *teleo-eval-orchestrator v2*
m3taversal closed this pull request 2026-03-15 17:20:42 +00:00

Pull request closed

This pull request cannot be reopened because the branch was deleted.
Sign in to join this conversation.
Reviewers
No reviewers
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#902
No description provided.
Delete branch "extract/2021-02-00-mckinsey-facility-to-home-265-billion-shift"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?